We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Cayman N4-Bz-5-O-DMTr-2-O-Methylcytidine-3-CED Phosphoramidite, 1 g
List Price $138.00 Your Price $138.00
Cayman N4-Bz-5-O-DMTr-2-O-Methylcytidine-3-CED Phosphoramidite, 1 g-CAYM (Additional S&H Or Hazmat Fees May Apply)
NETA PART: CAYM-43574-1
MFG.PART: 43574-1
UNSPSC: 12352200
Manufacturer: Cayman


Product Description
N4-Bz-5-O-DMTr-2-O-Methylcytidine-3-CED phosphoramidite is a nucleoside building block.
WARNING This product is not for human or veterinary use.
Technical Information
| Formal Name | N-benzoyl-5′-O- |
| CAS Number | 110764-78-8 |
| Molecular Formula | C47H54N5O9P |
| Formula Weight | 863.9 |
| Purity | ≥95% |
| Formulation(Request formulation change) | A solid |
| Solubility(Learn about Variance in Solubility) | DMSO: Sparingly Soluble: 1-10 mg/mLEthanol: Sparingly Soluble: 1-10 mg/mL |
| SMILES | N#CCCOP(O[C@@H]([C@H]1OC)[C@H](O[C@H]1N2C=CC(NC(C3=CC=CC=C3)=O)=NC2=O)COC(C(C=C4)=CC=C4OC)(C5=CC=CC=C5)C(C=C6)=CC=C6OC)N(C(C)C)C(C)C |
| InChi Code | InChI=1S/C47H54N5O9P/c1-32(2)52(33(3)4)62(59-30-14-28-48)61-42-40(60-45(43(42)57-7)51-29-27-41(50-46(51)54)49-44(53)34-15-10-8-11-16-34)31-58-47(35-17-12-9-13-18-35,36-19-23-38(55-5)24-20-36)37-21-25-39(56-6)26-22-37/h8-13,15-27,29,32-33,40,42-43,45H,14,30-31H2,1-7H3,(H,49,50,53,54)/t40-,42-,43-,45-,62?/m1/s1 |
| InChi Key | JFFSFQRVIPPCBC-VKBHKTMGSA-N |
Shipping & Storage Information
| Storage | -20°C |
| Shipping | Room temperature in continental US; may vary elsewhere |
| Stability | ≥ 4 years |
| SKU | CAYM-43574-1 |
|---|---|
| Supplier Part Number | 43574-1 |
| UM | EA |
| UNSPSC | 12352200 |
| Manufacturer | Cayman |
| Temperature | -20 |
| Refrigerated-Frozen | Y |
| CountryOfOrigin | China |
| ProductLine | CAYM |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 5 |
| Hazardous | N |
| CAS Number | 110764-78-8 |
| Energy Star | No |
| Green | No |
| Controlled | N |

